Skip to main content
PMC home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2003;10(5):514–524. doi: 10.1245/ASO.2003.11.005

Intraperitoneal Photodynamic Therapy Causes a Capillary-Leak Syndrome

Robert J Canter 1, Rosemarie Mick 2, Susan B Kesmodel 1, Dan J Raz 1, Francis R Spitz 1, James M Metz 3, Eli J Glatstein 3, Stephen M Hahn 3, Douglas L Fraker 1,4,✉
PMCID: PMC7101738  PMID: 12794017

Abstract

Background: In patients undergoing intraperitoneal (IP) photodynamic therapy (PDT), the combination of aggressive surgical debulking and light therapy causes an apparent systemic capillary-leak syndrome that necessitates significant intensive care unit (ICU) management after surgery.

Methods: From May 1997 to May 2001, 65 patients underwent surgical debulking and PDT as part of an ongoing phase II trial for disseminated IP cancer. Perioperative data were reviewed retrospectively, and statistical analyses were performed to determine whether any identifiable factors were associated with the need for mechanical ventilation for longer than 1 day and with the occurrence of postoperative complications.

Results: Forty-three women and 22 men (mean age, 49 years) were treated. Operative time averaged 9.8 hours, and mean estimated blood loss was 1450 mL. The mean crystalloid requirement for the first 48 hours after surgery was 29.3 L, and 49 patients required blood products. Twenty-four patients were intubated for longer than 24 hours, with a mean of 8.3 days for those intubated longer than 1 day. The median ICU stay was 4 days. Overall, 110 complications developed in 45 (69%) of the 65 patients. Significant complications included 6 patients with acute respiratory distress syndrome, 28 patients with infectious complications, and 4 patients with anastomotic complications. Statistical analyses revealed that surgery-related factors were significantly associated with these complication outcomes.

Conclusions: Patients who undergo surgical debulking and IP PDT develop a significant capillary-leak syndrome after surgery that necessitates massive volume resuscitation, careful ICU monitoring, and, frequently, prolonged ventilatory support.

Key Words: Photodynamic therapy, Carcinomatosis, Sarcomatosis, Capillary-leak syndrome

REFERENCES

  • 1.Berek JS, Bertelsen K, du Bois A, et al. Advanced epithelial ovarian cancer: 1998 consensus statements. Ann Oncol. 1999;10((Suppl 1)):87–92. doi: 10.1023/a:1008323922057. [DOI] [PubMed] [Google Scholar]
  • 2.Schellinx ME, von Meyenfeldt MF, Sugarbaker PH. Peritoneal carcinomatosis from adenocarcinoma of the colon. Cancer Treat Res. 1996;81:247–260. doi: 10.1007/978-1-4613-1245-1_21. [DOI] [PubMed] [Google Scholar]
  • 3.Ng EH, Pollock RE, Munsell MF, et al. Prognostic factors influencing survival in gastrointestinal leiomyosarcomas. Implications for surgical management and staging. Ann Surg. 1992;215:68–77. doi: 10.1097/00000658-199201000-00010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Benson RC., Jr. Laser photodynamic therapy for bladder cancer. Mayo Clin Proc. 1986;61:859–864. doi: 10.1016/s0025-6196(12)62606-8. [DOI] [PubMed] [Google Scholar]
  • 5.Dougherty TJ, Gomer CJ, Henderson BW, et al. Photodynamic therapy. J Natl Cancer Inst. 1998;90:889–905. doi: 10.1093/jnci/90.12.889. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Oleinick NL, Evans HH. The photobiology of photodynamic therapy: cellular targets and mechanisms. Radiat Res. 1998;150((5 Suppl)):S146–56. [PubMed] [Google Scholar]
  • 7.Gomer CJ, Dougherty TJ. Determination of [3H]- and [14C]hematoporphyrin derivative distribution in malignant and normal tissue. Cancer Res. 1979;39:146–151. [PubMed] [Google Scholar]
  • 8.Peng Q, Soler AM, Warloe T, et al. Selective distribution of porphyrins in skin thick basal cell carcinoma after topical application of methyl 5-aminolevulinate. J Photochem Photobiol B. 2001;62:140–145. doi: 10.1016/S1011-1344(01)00173-7. [DOI] [PubMed] [Google Scholar]
  • 9.Hendren SK, Hahn SM, Spitz FR, et al. Phase II trial of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors. Ann Surg Oncol. 2001;8:65–71. doi: 10.1007/s10434-001-0065-x. [DOI] [PubMed] [Google Scholar]
  • 10.DeLaney TF, Sindelar WF, Tochner Z, et al. Phase I study of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors. Int J Radiat Oncol Biol Phys. 1993;25:445–457. doi: 10.1016/0360-3016(93)90066-5. [DOI] [PubMed] [Google Scholar]
  • 11.Sindelar WF, DeLaney TF, Tochner Z, et al. Technique of photodynamic therapy for disseminated intraperitoneal malignant neoplasms. Phase I study. Arch Surg. 1991;126:318–324. doi: 10.1001/archsurg.1991.01410270062011. [DOI] [PubMed] [Google Scholar]
  • 12.Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994;149((3 Pt 1)):818–824. doi: 10.1164/ajrccm.149.3.7509706. [DOI] [PubMed] [Google Scholar]
  • 13.Gurevich I. Surgical site infections: simplifying the definitions. Infect Control Hosp Epidemiol. 1995;16:667–668. doi: 10.1086/647034. [DOI] [PubMed] [Google Scholar]
  • 14.Bone RC. Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS) Ann Intern Med. 1996;125:680–687. doi: 10.7326/0003-4819-125-8-199610150-00009. [DOI] [PubMed] [Google Scholar]
  • 15.Lemeshow S, Hosmer DW., Jr. Estimating odds ratios with categorically scaled covariates in multiple logistic regression analysis. Am J Epidemiol. 1984;119:147–151. doi: 10.1093/oxfordjournals.aje.a113732. [DOI] [PubMed] [Google Scholar]
  • 16.Vollset SE, Hirji KF, Afifi AA. Evaluation of exact and asymptotic interval estimators in logistic analysis of matched case-control studies. Biometrics. 1991;47:1311–1325. [PubMed] [Google Scholar]
  • 17.Hirji KF, Elashoff RM, Moore DH, II, Bennett DE. Exact versus asymptotic analysis for a matched case-control study. Stat Med. 1988;7:765–772. doi: 10.1002/sim.4780070706. [DOI] [PubMed] [Google Scholar]
  • 18.Bone RC. Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and do not know about cytokine regulation. Crit Care Med. 1996;24:163–172. doi: 10.1097/00003246-199601000-00026. [DOI] [PubMed] [Google Scholar]
  • 19.Moore FA, Moore EE, Read RA. Postinjury multiple organ failure: role of extrathoracic injury and sepsis in adult respiratory distress syndrome. New Horiz. 1993;1:538–549. [PubMed] [Google Scholar]
  • 20.Oberholzer A, Oberholzer C, Moldawer LL. Cytokine signaling—regulation of the immune response in normal and critically ill states. Crit Care Med. 2000;28((4 Suppl)):N3–12. doi: 10.1097/00003246-200004001-00002. [DOI] [PubMed] [Google Scholar]
  • 21.Gogos CA, Drosou E, Bassaris HP, Skoutelis A. Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. J Infect Dis. 2000;181:176–180. doi: 10.1086/315214. [DOI] [PubMed] [Google Scholar]
  • 22.Pinsky MR, Vincent JL, Deviere J, et al. Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest. 1993;103:565–575. doi: 10.1378/chest.103.2.565. [DOI] [PubMed] [Google Scholar]
  • 23.Hotchkiss RS, Swanson PE, Freeman BD, et al. Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med. 1999;27:1230–1251. doi: 10.1097/00003246-199907000-00002. [DOI] [PubMed] [Google Scholar]
  • 24.Oberholzer C, Oberholzer A, Clare-Salzler M, Moldawer LL. Apoptosis in sepsis: a new target for therapeutic exploration. FASEB J. 2001;15:879–892. doi: 10.1096/fj.00-058rev. [DOI] [PubMed] [Google Scholar]
  • 25.Belghiti J, Hiramatsu K, Benoist S, et al. Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg. 2000;191:38–46. doi: 10.1016/s1072-7515(00)00261-1. [DOI] [PubMed] [Google Scholar]
  • 26.Yeo CJ, Cameron JL, Sohn TA, et al. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg. 1997;226:248–257. doi: 10.1097/00000658-199709000-00004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Orringer MB, Marshall B, Iannettoni MD. Transhiatal esophagectomy: clinical experience and refinements. Ann Surg. 1999;230:392–400. doi: 10.1097/00000658-199909000-00012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Jacquet P, Stephens AD, Averbach AM, et al. Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy. Cancer. 1996;77:2622–2629. doi: 10.1002/(SICI)1097-0142(19960615)77:12<2622::AID-CNCR28>3.0.CO;2-T. [DOI] [PubMed] [Google Scholar]
  • 29.Stephens AD, Alderman R, Chang D, et al. Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol. 1999;6:790–796. doi: 10.1007/s10434-999-0790-0. [DOI] [PubMed] [Google Scholar]
  • 30.Alonso O, Sugarbaker PH. Adult respiratory distress syndrome occurring in two patients undergoing cytoreductive surgery plus perioperative intraperitoneal chemotherapy: case reports and a review of the literature. Am Surg. 2000;66:1032–1036. [PubMed] [Google Scholar]
  • 31.Esquivel J, Angulo F, Bland RK, et al. Hemodynamic and cardiac function parameters during heated intraoperative intraperitoneal chemotherapy using the open “coliseum technique”. Ann Surg Oncol. 2000;7:296–300. doi: 10.1007/s10434-000-0296-2. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgical Oncology are provided here courtesy of Nature Publishing Group

RESOURCES